Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
VIVO Cannabis Inc.
VVCIF
Healthcare
Drug Manufacturers - Specialty & Generic
VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical...
locations - Canada, Germany, and Australia.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:VVCIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(34)
•••
Kylemcc10
X
View Profile
View Bullboard History
Comment by
Kylemcc10
on Jun 25, 2023 5:08pm
RE:100 correct
Wow vivo was the first stock I ever bought over 5 years ago. Sad to see what's it's become, funny to see some familiar names in here still. I had lots of hope early on, made a bit of money
...more
(52)
•••
buddy12
X
View Profile
View Bullboard History
Post by
buddy12
on Apr 18, 2023 1:28pm
100 correct
That this pos was never intended to succeed...it WAS however a vehicle for the exec class....THRY were solely the intended party to remain I. Their lofty stead ....how many moved on from the first
...more
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
posted Dec 22, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more
(2)
•••
Constable
X
View Profile
View Bullboard History
Comment by
Constable
on Apr 17, 2023 7:28pm
RE:Well the theft from vivo share holders
Have 77k shares 4 yrs mghtas we'll hang in there every dog has its day
(39)
•••
Hempminister
X
View Profile
View Bullboard History
Post by
Hempminister
on Apr 17, 2023 10:59am
Well the theft from vivo share holders
Is almost complete The 300 million share man wins . And labs shakes his hold completely . Not that it will matter much the sector itself is a joke and will remain so for the foreseeable
...more
(44)
•••
rusty777
X
View Profile
View Bullboard History
Comment by
rusty777
on Apr 05, 2023 2:23pm
RE:Vivo delisted as of this morning !!!
That would be nice - sure can't make it much weaker....I sure hope they have had the good sense to ditch ALL the senior management and BoD of VIVO!!!! If they did - then we have a chance
...more
(36)
•••
Saskisnow
X
View Profile
View Bullboard History
Comment by
Saskisnow
on Apr 05, 2023 10:09am
RE:Vivo delisted as of this morning !!!
Oh ya, I'm sure we'll see $.08 someday.
(849)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Post by
1hot-techwoman
on Apr 05, 2023 7:15am
Vivo delisted as of this morning !!!
Looking to get your shares Medipharm now. Should make stronger company going forward !! GLTA :)
(849)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Comment by
1hot-techwoman
on Apr 04, 2023 8:45am
RE:RE:Vivo gets about 1/3 conversion rate in Labs shares !!!
Will convert automatically into your trading acct to labs shares at the conversion rate.... Cheers :)
(190)
•••
srtman03
X
View Profile
View Bullboard History
Comment by
srtman03
on Apr 03, 2023 8:56am
RE:Vivo gets about 1/3 conversion rate in Labs shares !!!
Are the shares of Vivo converted automatically to Labs shares (29.1) in your trading act...or do we have to do somthing else? Thanks
(849)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Post by
1hot-techwoman
on Apr 03, 2023 7:32am
Vivo gets about 1/3 conversion rate in Labs shares !!!
VIVO shareholders are entitled to receive 0.2910 of a common share of MediPharm (each whole share, a "MediPharm Share") in exchange for each VIVO Share held immediately prior to closing of
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 03, 2023 7:01am
New Press Release - MediPharm Labs Corp. Completes Acquisition of VIVO Cannabis Inc. and Confirms Final Ownership Ratio
BARRIE, ON, April 3, 2023 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", or "MediPharm Labs") and VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO") are pleased to announce the completion of the previously announced plan of arrangement under section 192 of...
read article.
(44)
•••
rusty777
X
View Profile
View Bullboard History
Comment by
rusty777
on Mar 31, 2023 5:05pm
RE:RE:RE:RE:Value per share
It will depend on what they decide the conversion rate will be. It should be some time in the next few weeks if this News Release is accurate: Completion of the Arrangement is subject to court
...more
(849)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Post by
1hot-techwoman
on Mar 31, 2023 7:22am
Medipharm driving toward profitability $$$$
Management Commentary David Pidduck, CEO, MediPharm Labs commented, "2022 was a transformative year for MediPharm. We have transitioned our focus away from Canadian B2B sales, exited less
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 28, 2023 7:28am
New Press Release - VIVO Cannabis Announces Fourth Quarter 2022 Results
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter.Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021.Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year.The Company signed a definitive agreement with MediPharm Labs...
read article.
(2)
•••
Constable
X
View Profile
View Bullboard History
Comment by
Constable
on Mar 27, 2023 1:58pm
RE:RE:RE:Value per share
When do I find out how many shares of medi I hold now.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments